Compare PROF & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | RCMT |
|---|---|---|
| Founded | N/A | 1971 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.1M | 196.0M |
| IPO Year | 2017 | 1997 |
| Metric | PROF | RCMT |
|---|---|---|
| Price | $6.24 | $28.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 215.8K | 66.3K |
| Earning Date | 05-07-2026 | 04-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.89 | ★ 27.38 |
| EPS | 1.41 | ★ 2.14 |
| Revenue | $16,098,000.00 | ★ $186,737,000.00 |
| Revenue This Year | $92.40 | $8.37 |
| Revenue Next Year | $64.10 | N/A |
| P/E Ratio | ★ $4.45 | $13.25 |
| Revenue Growth | ★ 50.73 | 5.83 |
| 52 Week Low | $3.92 | $15.29 |
| 52 Week High | $8.95 | $28.85 |
| Indicator | PROF | RCMT |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 78.72 |
| Support Level | $5.86 | $18.30 |
| Resistance Level | $7.02 | N/A |
| Average True Range (ATR) | 0.50 | 1.57 |
| MACD | 0.06 | 0.91 |
| Stochastic Oscillator | 65.29 | 92.63 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.